1. Home
  2. Products
  3. Customized FluoroAb™
  4. IL17RA
  5. Anti-IL17RA MAb (Clone 3)-iFluor® 350 Succinimidyl Ester

Anti-IL17RA MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1321)

This product is comprised of an Human Anti-IL17RA IgG2-kappa (Clone 3) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • IL17RA
  • Overview
  • Human Anti-IL17RA IgG2-kappa (Clone 3)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 350 Succinimidyl Ester
  • Color
  • Blue
  • Excitation⁄Emission (nm)
  • 345/450
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS1321. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-1326 Anti-IL17RA (Ixekizumab)-MC-Vc-PAB-SN38 ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin)
ADC-W-1324 Anti-IL17RA (Ixekizumab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF
ADC-W-1316 Anti-IL17RA (Brodalumab)-SMCC-DM1 ADC SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-1323 Anti-IL17RA (Ixekizumab)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
ADC-W-1325 Anti-IL17RA (Ixekizumab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.